Inhibition of PGC-1α by shRNA- silencing resensitized breast cancer cells to phenformin and reduced their ability to withstand glucose withdrawal, suggesting an important role for PGC-1α in coordinating metabolic processes for cancer cell survival [59]. This evidence concerns the gene PPARGC1A and breast carcinoma.